Approval for the infuse bone graft/lt-cage lumbar tapered fusion device.  This device is indicated for spinal fusion procedures in skeletally mature patients with degenerative disc disease (ddd) at one level from l4-s1.  Ddd is defined as discogenic back pain with degeneration of the disc confirmed by patient history, function deficit and/or neurological deficit and radiographic studies.  These ddd patients may also have up to grade i spondylolisthesis at the involved level.  Infuse bone graft/lt-cage devices are to be implanted via an anterior open or an anterior laparoscopic approach.  Patients receiving the infuse bone graft/lt-cage lumbar tapered fusion device should have had at least six months of nonoperative treatment prior to treatment with the infuse bone graft/lt-cage device.